TRIANNI and Olympic Protein Technologies Sign License Agreement for The Trianni Mouse™

San Francisco, CA and Seattle, WA, USA., May 24, 2017 –Trianni, Inc. (“TRIANNI”) and Olympic Protein Technologies (“Olympic”) jointly announced today that Olympic has entered into a license agreement for The Trianni Mouse, a best-in-class monoclonal antibody discovery platform.

“TRIANNI is pleased to bolster Olympic’s lead generation capabilities through a license to The Trianni Mouse,” stated Dr. David Meininger, TRIANNI’s Chief Business Officer. “We’re confident that Olympic’s deep expertise in target characterization will potently synergize with the industry-leading human antibody repertoires provided by The Trianni Mouse™.”

“We are looking forward to integrating TRIANNI’s state-of-the-art antibody technology into our expanding set of protein science capabilities”, said Dr. Michael Wittekind, CEO of Olympic Protein Technologies.  “The TRIANNI platform is an outstanding solution for antibody discovery which will greatly benefit the programs we perform at Olympic Protein Technologies.”

No financial details were disclosed.


TRIANNI is a privately held biotech company specializing in human antibody discovery technology. TRIANNI’s lead technology, The Trianni Mouse™, is a powerful, next-generation platform enabling efficient generation of fully-human monoclonal antibodies. TRIANNI’s transgenic platform leverages a novel approach to design made possible by advances in DNA synthesis and genomic modification technology making it a best-in-class therapeutic antibody discovery platform.  The company is headquartered in San Francisco, CA. Additional information about TRIANNI is available through its corporate website,


About Olympic Protein Technologies
Olympic Protein Technologies (Olympic Protein Sciences LLC) is a privately held biotechnology company focused on enabling partners and clients by providing high quality protein services. Olympic Protein Technologies is staffed by experienced biotechnology industry professionals who specialize in protein expression/production/characterization, antigen preparation, antibody discovery, and protein engineering. The company is headquartered in Seattle, WA. Additional information about Olympic Protein Technologies is available through its corporate website,


Contact- Trianni, Inc
David Meininger
Chief Business Officer


Mandy Boyd
Director of Marketing
1.415.231.0256 [o]


Contact – Olympic Protein Technologies
Michael Wittekind
Chief Executive Officer